Known targets — ChEMBL curated mechanism
ADRA1AADRA1BADRA1DADRB1ADRB2ADRB3CYP11B1DPP4FGFR1FGFR2FGFR3FGFR4HRH1JAK1JAK2JAK3KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITNAOPRD1OPRK1OPRM1PPDGFRBPIK3CDSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASMOTYK2polrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 2/20 | 0.88 |
| ▸ | FAAH | O00519 | 5/20 | 0.57 |
| ▸ | LPAR1 | Q92633 | 4/20 | 0.56 |
| ▸ | NAAA | Q02083 | 1/20 | 0.56 |
| ▸ | CASP2 | P42575 | 1/20 | 0.54 |
| ▸ | LPAR2 | Q9HBW0 | 3/20 | 0.50 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.50 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.49 |
| ▸ | SELP | P16109 | 1/20 | 0.49 |
| ▸ | THRA | P10827 | 1/20 | 0.48 |
| ▸ | THRB | P10828 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL9843964 | 1.00 | DNM1 (0.88) | DNM1FAAHLPAR1NAAACASP2 | |
| SCHEMBL9565176 | 0.94 | DNM1 (1.00) | DNM1FAAHNAAACASP2EPHX2 | |
| SCHEMBL8660980 | 0.94 | DNM1 (1.00) | DNM1FAAHNAAACASP2EPHX2 | |
| SCHEMBL19281112 | 0.94 | DNM1 (1.00) | DNM1FAAHNAAACASP2EPHX2 | |
| SCHEMBL74418 | 0.94 | DNM1 (1.00) | DNM1FAAHNAAACASP2EPHX2 | |
| SCHEMBL8780431 | 0.94 | DNM1 (1.00) | DNM1FAAHNAAACASP2EPHX2 | |
| SCHEMBL3318222 | 0.94 | DNM1 (1.00) | DNM1FAAHNAAACASP2EPHX2 | |
| SCHEMBL15994307 | 0.94 | DNM1 (1.00) | DNM1FAAHNAAACASP2EPHX2 | |
| SCHEMBL5383341 | 0.94 | DNM1 (1.00) | DNM1FAAHNAAACASP2EPHX2 | |
| SCHEMBL7924413 | 0.94 | DNM1 (1.00) | DNM1FAAHNAAACASP2EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 306 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190099342-A1 | COOLING PRODUCT | SYMRISE AG (DE) | 2019-04-04 | — | — | US | claimed |
| US-8158567-B1 | Body cleansing composition | DEANE JEFFREY ALAN (US) | 2012-04-17 | — | — | US | claimed |
| US-7977290-B1 | Body cleansing composition | DEANE JEFFREY ALAN | 2011-07-12 | — | — | US | claimed |
| WO-2008081348-A2 | METHOD AND COMPOSITION FOR PERMANENTLY SHAPING HAIR | THE PROCTER & GAMBLE COMPANY (US) | 2008-07-10 | — | — | WO | claimed |
| US-20080025937-A1 | Method and composition for permanently shaping hair | PROCTER & GAMBLE COMPANY, THE | 2008-01-31 | — | — | US | claimed |
| EP-1880709-A1 | Method and composition for permanently shaping hair | Wella Aktiengesellschaft (DE) | 2008-01-23 | — | — | EP | claimed |
| EP-0437006-B1 | Composition that protects dyed hair from fading | COLGATE PALMOLIVE CO (US) | 1994-12-07 | — | — | EP | claimed |
| EP-0437006-A1 | Composition that protects dyed hair from fading | Colgate-Palmolive Company (US) | 1991-07-17 | — | — | EP | claimed |
| US-12629327-B2 | Keratin-based hair straightening formulations, methods and systems | BEAUTY BIOLABS LLC (US) | 2026-05-19 | — | — | US | disclosed |
| WO-2026087745-A1 | AN ANTIOXIDANT COMPOSITION COMPRISING A CINNAMIC ACID DERIVATIVE | BRAIN Biotech AG (DE) | 2026-04-30 | — | — | WO | disclosed |
| EP-4732825-A1 | AN ANTIOXIDANT COMPOSITION COMPRISING A CINNAMIC ACID DERIVATIVE | BRAIN Biotech AG (DE) | 2026-04-29 | — | — | EP | disclosed |
| US-20260096978-A1 | A METHOD FOR PREVENTING, MITIGATING AND/OR TREATING PTGS2-INDUCED SKIN DISORDERS AND RELATED DYSFUNCTIONS | SYMRISE AG (DE) | 2026-04-09 | — | — | US | disclosed |
| EP-4025675-B1 | A PERFUME OIL MIXTURE | SYMRISE AG (DE) | 2026-03-18 | — | — | EP | disclosed |
| US-20260047994-A1 | AN ACTIVE COMPOSITION COMPRISING RETINOL | SYMRISE AG (DE) | 2026-02-19 | — | — | US | disclosed |
| EP-0757560-A1 | USE OF AMIDOAMINES IN OPHTHALMIC COMPOSITIONS | ALCON LABORATORIES, INC. (US) | 1997-02-12 | — | — | EP | disclosed |
| WO-1996026747-A2 | USE OF AMIDOAMINES IN OPHTHALMIC COMPOSITIONS | ALCON LABORATORIES, INC. (US) | 1996-09-06 | — | — | WO | disclosed |
| EP-0669803-A1 | USE OF AMIDOAMINES IN OPHTHALMIC COMPOSITIONS | ALCON LABORATORIES, INC. (US) | 1995-09-06 | — | — | EP | disclosed |
| WO-1995008266-A1 | USE OF AMIDOAMINES IN OPHTHALMIC COMPOSITIONS | ALCON LABORATORIES, INC. (US) | 1995-03-30 | — | — | WO | disclosed |
| EP-0437006-B1 | Composition that protects dyed hair from fading | COLGATE PALMOLIVE CO (US) | 1994-12-07 | — | — | EP | disclosed |
| US-5045307-A | Sunscreen agents, hydroxybenzophenones, incorporated into shampoo, hair conditioners | COLGATE-PALMOLIVE COMPANY (US) | 1991-09-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190099342-A1 | COOLING PRODUCT | TRPA1, TRPV2, NISCH | DNM1 4365/4885FAAH 53/4885LPAR1 3741/4885 |
| US-12629327-B2 | Keratin-based hair straightening formulations, methods and systems | KRT18, HCN4, COL14A1 | DNM1 3619/4885FAAH 3621/4885LPAR1 2979/4885 |
| US-20080025937-A1 | Method and composition for permanently shaping hair | DNMT3A, DNMT1, NACA | DNM1 1517/4885FAAH 1798/4885LPAR1 1881/4885 |
| US-20260047994-A1 | AN ACTIVE COMPOSITION COMPRISING RETINOL | RBP4, LRAT, RARB | DNM1 3641/4885FAAH 660/4885LPAR1 709/4885 |
| US-20260096978-A1 | A METHOD FOR PREVENTING, MITIGATING AND/OR TREATING PTGS2-INDUCED SKIN DISORDERS AND RELATED DYSFUNCTIONS | PTGS2, PTGES2, PTGS1 | DNM1 4837/4885FAAH 464/4885LPAR1 1695/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.